De-juan Wang1 article listing De-juan Wang in Nature Communications, indexed by Paperzzz from Crossref and OSF.Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial Nature Communications